Search Results - "Scholler, N"
-
1
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
Published in Gynecologic oncology (01-10-2004)“…The serum tumor marker CA 125 is elevated in most clinically advanced ovarian carcinomas. Because these elevations may precede clinical detection by a year or…”
Get full text
Journal Article -
2
CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells
Published in The Journal of immunology (1950) (15-03-2001)“…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
Get full text
Journal Article -
3
Immunotherapy: TNFR2 AS A TARGET TO IMPROVE CD19-DIRECTED CART CELL FITNESS AND ANTITUMOR ACTIVITY IN LARGE B CELL LYMPHOMA
Published in Cytotherapy (Oxford, England) (01-05-2022)Get full text
Journal Article -
4
Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers
Published in Clinical cancer research (01-04-2006)“…Purpose: Efforts to validate ovarian cancer early detection biomarkers with immunoassays are challenged by the limited specimen volumes available. We sought to…”
Get full text
Journal Article -
5
Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer
Published in JNCI : Journal of the National Cancer Institute (02-11-2011)“…In screening for epithelial ovarian cancer, unnecessary surgery can be reduced by limiting use of transvaginal ultrasound (TVU) to women with increasing CA125…”
Get full text
Journal Article -
6
Soluble Member(s) of the Mesothelin/Megakaryocyte Potentiating Factor Family are Detectable in Sera from Patients with Ovarian Carcinoma
Published in Proceedings of the National Academy of Sciences - PNAS (28-09-1999)“…mAb OV569 was made by immunizing mice with ovarian carcinoma cells. It binds to cells from ovarian carcinomas and, to a lesser extent, to cells from certain…”
Get full text
Journal Article -
7
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating
Published in Journal of immunological methods (20-12-2006)“…We describe here a novel method for generation of yeast-secreted, in vivo biotinylated recombinant antibodies, or biobodies. Biobodies are secreted by diploid…”
Get full text
Journal Article -
8
Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer ne ovas cularization
Published in Neoplasia (New York, N.Y.) (01-11-2012)“…Complement activation plays a critical role in controlling inflammatory responses. To assess the role of complement during ovarian cancer progression, we…”
Get full text
Journal Article -
9
Cutting Edge: CD83 Regulates the Development of Cellular Immunity
Published in The Journal of immunology (1950) (15-03-2002)“…We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8(+)…”
Get full text
Journal Article -
10
CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells
Published in The Journal of immunology (1950) (01-02-2009)Get full text
Journal Article -
11
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity
Published in Molecular cancer therapeutics (01-10-2003)“…DNA vaccines are ideally suited for immunizing against tumor antigens because constructs can be formulated that not only encode the tumor antigen but also…”
Get full text
Journal Article -
12
CD3-Mediated Activation of Tumor-Reactive Lymphocytes from Patients with Advanced Cancer
Published in Proceedings of the National Academy of Sciences - PNAS (05-06-2001)“…Lymphocytes from blood or tumors of patients with advanced cancer did not proliferate and produced very low levels of tumor necrosis factor and IFN-γ when…”
Get full text
Journal Article -
13
CD83 Regulates the Development of Cellular Immunity
Published in The Journal of immunology (1950) (15-03-2002)“…We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8…”
Get full text
Journal Article -
14
CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected]
Published in The Journal of immunology (1950) (15-03-2001)“…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
Get full text
Journal Article -
15
CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8 super(+) T Cells
Published in The Journal of immunology (1950) (15-03-2001)“…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
Get full text
Journal Article -
16
Development and In Vitro Validation of Anti-Mesothelin Biobodies that Prevent CA125/Mesothelin-dependent Cell Attachment
Published in Clinical immunology (Orlando, Fla.) (01-01-2007)Get full text
Journal Article